Title Page
Abstract
Contents
Ⅰ. INTRODUCTION 11
Ⅱ. METHODS 13
2.1. ETHICAL CONSIDERATIONS 13
2.2. STUDY DESIGN AND PARTICIPANTS 13
2.3. BIOCHEMICAL EVALUATION 16
2.4. GAS CHROMATOGRAPHY 17
2.5. STATISTICAL ANALYSIS 17
2.6. DROPOUT OF PARTICIPANTS 18
Ⅲ. RESULTS 18
3.1. CHARACTERISTICS OF THE PARTICIPANTS 18
3.2. ANALYSES OF THE CHANGES IN THE BIOCHEMICAL PARAMETERS 18
3.3. CHANGES IN THE ERYTHROCYTE MEMBRANE FATTY ACID CONTENTS 19
Ⅳ. Discussion 20
References 23
국문초록 36
Table 1. Blood clinical and biochemical analyses of the enrolled participants 30
Table 2. Comparative blood clinical and biochemical analyses at Baseline, 12 Weeks, and 24 Weeks, for paticipants undergoing peritoneal dialysis... 31
Table 3. Comparative erythrocyte membrane fatty acid content analyses at Baseline, 12 Weeks, and 24 Weeks, for participants undergoing peritoneal dialysis during the... 33
Figure 1. Study flow chart 28
Figure 2. Changes in the triglyceride levels from baseline to 12weeks during the icodextrin exposure periods 28
Figure 3. Changes in erythrocyte membrane oleic acid contents from baseline to 12 weeks during the (a)glucose exposure periods,... 29